Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||-1.42%||535.90||1.0%||$658.29m|
|ISRG||Intuitive Surgical, Inc.||-2.86%||201.99||0.8%||$426.39m|
|BSX||Boston Scientific Corp.||-0.87%||37.49||1.0%||$336.88m|
|ALGN||Align Technology, Inc.||-3.30%||241.92||6.4%||$298.14m|
|EW||Edwards Lifesciences Corp.||-2.16%||94.72||0.4%||$272.21m|
|BDX||Becton, Dickinson & Co.||-2.21%||244.58||1.0%||$270.07m|
|IDXX||IDEXX Laboratories, Inc.||-2.74%||349.21||3.8%||$224.75m|
|A||Agilent Technologies, Inc.||-2.87%||117.11||1.7%||$210.64m|
|BAX||Baxter International, Inc.||-2.11%||65.30||1.8%||$203.22m|
|SWAV||Shockwave Medical, Inc.||-1.33%||195.54||0.0%||$174.99m|
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.